ArticleDiabetologia2024

Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns.

Mingwei Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.